Connected drug delivery devices to complement drug treatments: potential to facilitate disease management in home setting

References

• CheeTTRyanAMWasfyJHBordenWBCurrent state of value-based purchasing programsCirculation2016133222197220527245648
   PubMed Web of Science ®Google Scholar
• Le MassonGSoléGDesnuelleCHome versus hospital immunoglobulin treatment for autoimmune neuropathies: a cost minimization analysisBrain Behav201882e0092329484273
   PubMed Web of Science ®Google Scholar
• BittnerBRichterWSchmidtJSubcutaneous administration of biotherapeutics: an overview of current challenges and opportunitiesBioDrugs201832542544030043229
   PubMed Web of Science ®Google Scholar
• AllanSAdvanced Delivery Devices - How data hubs & smart devices are enabling the rise of therapeutic ecosystemsDrug Development & DeliveryJan-Feb2016 Available from: https://drug-dev.com/advanced-delivery-devices-how-data-hubs-smart-devices-are-enabling-the-rise-of-therapeutic-ecosystems/Accessed November 2, 2018
   Google Scholar
• AdheriumAdherium Launches the Hailie™ Global Brand to Connect People with Asthma and COPD to Better Care [press release] Available from: https://www.adherium.com/news/adherium-launches-the-hailie-global-brand-to-connect-people-with-asthma-and-copd-to-better-care/Accessed November 2018
   Google Scholar
• United States Food and Drug AdministrationMedical Device Overview992018 Available from: https://www.fda.gov/forindustry/importprogram/importbasics/regulatedproducts/ucm510630.htmAccessed November 2018
   Google Scholar
• European UnionRegulation EU 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation EC 178/2002 and Regulation EC1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC452017 Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32017R0745Accessed November 3, 2018
   Google Scholar
• United States Food and Drug Administration 510(k) Premarket Notification992018 Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfmAccessed November 2018
   Google Scholar
• United States Food and Drink AdministrationBetaconnect – supplemental BLA letters9252015 Available from: https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/103471Orig1s5186ltr.pdfAccessed November 4, 2018
   Google Scholar
• United States Food and Drink AdministrationDrug Approval Package: Abilify MyCite (aripiprazole)9132017 Available from: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/207202Orig1s000TOC.cfmAccessed November 4, 2018
   Google Scholar
• Proteus Digital Health8132010 Available from: www.proteus.com/press-releases/proteus-biomedical-announces-european-ce-mark-approval-of-ingestible-sensor-and-monitor-system/Accessed November 4, 2018
   Google Scholar
• ExcellSThristanMDangondFMarhardtKSt Charles-KroheMTurner-BowkerDMA novel electronic application of patient-reported outcomes in multiple sclerosis – Meeting the necessary challenge of assessing quality of life and outcomes in daily clinical practiceEur Neurolog Rev2014914955
   Google Scholar
• National Institute for Health and Care ExcellenceSmartinhaler for asthma1112017 Available from: https://www.nice.org.uk/guidance/mib90/resources/smartinhaler-for-asthma-pdf-63499461673669Accessed November 4, 2018
   Google Scholar
• PropellerPropeller Health receives FDA clearance for the Propeller platform in association with GSK’s Elipta® inhaler7112016 Available from: https://www.propellerhealth.com/2016/11/07/propeller-health-receives-fda-clearance-for-the-propeller-platform-in-association-with-gsks-ellipta-inhaler/Accessed November 4, 2018
   Google Scholar
• European Medicines AgencyQualification opinion on ingestible sensor system for medication adherence as biomarker for measuring patient adherence to medication in clinical trials2152016 Available from: https://www.ema.europa.eu/documents/regulatory-procedural-guideline/qualification-opinion-ingestible-sensor-system-medication-adherence-biomarker-measuring-patient_en.pdfAccessed November 4, 2018
   Google Scholar
• LugaresiARebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherenceExpert Opin Drug Deliv201310227328323252744
   PubMed Web of Science ®Google Scholar
• BayasAImproving adherence to injectable disease-modifying drugs in multiple sclerosisExpert Opin Drug Deliv201310328528723339371
   PubMed Web of Science ®Google Scholar
• BayasAOualletJCKallmannBAdherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational smart studyExpert Opin Drug Deliv20151281239125026098143
   PubMed Web of Science ®Google Scholar
• FernándezOArroyoRMartínez-YélamosSLong-term adherence to IFN beta-1a treatment when using RebiSmart® device in patients with relapsing-remitting multiple sclerosisPLoS One2016118e016031327526201
   PubMed Web of Science ®Google Scholar
• PaolicelliDCoccoEDi LecceVExploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: tracer studyExpert Opin Drug Deliv20161361726558898
   PubMed Web of Science ®Google Scholar
• DevonshireVAFeinsteinAMoriartyPAdherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV studyBMC Res Notes2016914826951043
   PubMedGoogle Scholar
• MocciaMPalladinoRRussoCHow many injections did you miss last month? A simple question to predict interferon beta-1a adherence in multiple sclerosisExpert Opin Drug Deliv201512121829183526371561
   PubMed Web of Science ®Google Scholar
• SolsonaMDEBoquetEMEstruchBCImpact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart® in patients with multiple sclerosisPatient Prefer Adherence20171141542128280313
   PubMed Web of Science ®Google Scholar
• WillisHWebsterJLarkinAMParkesLAn observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart(®) injection devicePatient Prefer Adherence2014884385124966669
   PubMed Web of Science ®Google Scholar
• ZeccaCDisantoGMühlSGobbiCSubjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE studyBMC Neurol201717117128870152
   PubMed Web of Science ®Google Scholar
• PedersenEDStenagerEVadgaardJLAdherence to subcutaneous interferon beta-1a treatment using an electronic injection device: a prospective open-label Scandinavian noninterventional study (the ScanSmart study)Patient Prefer Adherence20181256957529720872
   PubMed Web of Science ®Google Scholar
• RauDRoßnagelFGösslingJAdherence, cognition and behavioral performance in relapsing-remitting MS RRMS patients using the electronic autoinjector RebiSmart: 1 and 2-year follow-up from the German multicenter RebiSmart studyMult Scler J2017233 Suppl889890
   Google Scholar
• LugaresiAFlorioCBrescia-MorraVPatient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV studyBMC Neurol201212722390218
   PubMed Web of Science ®Google Scholar
• LugaresiADe RobertisFClericoMLong-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER studyExpert Opin Drug Deliv201613793193526909646
   PubMed Web of Science ®Google Scholar
• GhezziABianchiABaronciniDA multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmart™-the FUTURE studyNeurol Sci201738111999200528831635
   PubMed Web of Science ®Google Scholar
• ZiemssenTSylvesterLRamettaMRossAPPatient satisfaction with the new interferon beta-1b autoinjector (BETACONNECT™)Neurol Ther20154212513626662362
   PubMedGoogle Scholar
• KleiterILangMJeskeJAdherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT™ autoinjector: a prospective observational cohort studyBMC Neurol201717117428877664
   PubMed Web of Science ®Google Scholar
• PattiFMartínez GinésMLNorenbergCDuarte CaronFBetaEval Global: Prospective, non-interventional, multinational, observational cohort study of patients using BETACONNECTMult Scler J2017233 Suppl954
   Google Scholar
• RamettaMGerminoRMcleodKImpact of Betaconnect auto-injector on patient adherence of betaseron therapyAnnual meeting of the Consortium of Multiple Sclerosis Centers2017 May 24-27New Orleans, LA, USA
   Google Scholar
• BelknapRWeisSBrookensAFeasibility of an ingestible sensor-based system for monitoring adherence to tuberculosis therapyPLoS One201381e5337323308203
   PubMed Web of Science ®Google Scholar
• FriasJVirdiNRajaPKimYSavageGOsterbergLEffectiveness of digital medicines to improve clinical outcomes in patients with uncontrolled hypertension and type 2 diabetes: prospective, open-label, cluster-randomized pilot clinical trialJ Med Internet Res2017197e24628698169
   PubMed Web of Science ®Google Scholar
• MoorheadPZavalaAKimYVirdiNSEfficacy and safety of a medication dose reminder feature in a digital health offering with the use of sensor-enabled medicinesJ Am Pharm Assoc2017572155161
   Google Scholar
• DicarloLKimYAYoungJBezhadiYReal-time assessment of medication taking and activities of daily living in patients with uncontrolled hypertensionValue Health2014177A475
   Web of Science ®Google Scholar
• GodbeherePWareingPHypertension assessment and management: role for digital medicineJ Clin Hypertens2014163235
   Web of Science ®Google Scholar
• NaikRMaceyNWestRJFirst use of an ingestible sensor to manage uncontrolled blood pressure in primary practice: the UK hypertension registryJ Community Med Health Educ20177115
   Google Scholar
• BonaciniMYaKPitneyCA novel digital medicine offering to assess and optimize adherence for oral hepatitis C treatmentHepatol201766Suppl 1394A
   Google Scholar
• SullivanSCutrightLMcConnellLUse of digitized medications to enhance adherence and transplant outcomesPediatr Transplant201721Supplement 133
   Google Scholar
• Au-YeungKYDiCarloLCost comparison of wirelessly vs directly observed therapy for adherence confirmation in anti-tuberculosis treatmentInt J Tuberc Lung Dis201216111498150423006834
   PubMed Web of Science ®Google Scholar
• KimYAVirdiNRajaPDicarloLModeling the impact of a digital health feedback system in uncontrolled hypertensive patientsValue Health2014177A479
   Web of Science ®Google Scholar
• KimYARajaPDicarloLVirdiNParkHAn economic model of the impact of digital medicines with a mobile application in patients with comorbid hypertension, diabetes, and hypercholesterolemiaValue Health2015183A40
   Web of Science ®Google Scholar
• ChenAHHarrisonJBlackPNMitchellEAFosterJMUsing electronic monitoring devices to measure inhaler adherence: a practical guide for cliniciansJ Allergy Clin Immunol Pract20153333534925840665
   PubMed Web of Science ®Google Scholar
• MortonRWElphickHERigbyASSTAAR: A randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthmaThorax201772434735427815524
   PubMed Web of Science ®Google Scholar
• ChanAHYStewartAWHarrisonJCamargoCABlackPNMitchellEAThe effect of an electronic monitoring device with audiovisual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma: a randomised controlled trialLancet Respir Med20153321021925617215
   PubMed Web of Science ®Google Scholar
• BurgessSWSlyPDDevadasonSGProviding feedback on adherence increases use of preventive medication by asthmatic childrenJ Asthma201047219820120170329
   PubMed Web of Science ®Google Scholar
• CharlesTQuinnDWeatherallMAldingtonSBeasleyRHoltSAn audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthmaJ Allergy Clin Immunol2007119481181617320942
   PubMed Web of Science ®Google Scholar
• FosterJMUsherwoodTSmithLInhaler reminders improve adherence with controller treatment in primary care patients with asthmaJ Allergy Clin Immunol201413461260126825062783
   PubMed Web of Science ®Google Scholar
• BrittoMTRohanJMDoddsCMByczkowskiTLA randomized trial of user-controlled text messaging to improve asthma outcomes: a pilot studyClin Pediatr2017561413361344
   Web of Science ®Google Scholar
• KenyonCCChangJWynterSAFowlerJCLongJBryant-StephensTCElectronic adherence monitoring in a high-utilizing pediatric asthma cohort: a feasibility studyJMIR Res Protoc201652e13227335355
   PubMedGoogle Scholar
• MerchantRInamdarRHendersonKDigital health intervention for asthma: patient-reported value and usabilityJMIR Mhealth Uhealth201866e13329866644
   PubMed Web of Science ®Google Scholar
• MerchantRKInamdarRQuadeRCEffectiveness of population health management using the propeller health asthma platform: a randomized clinical trialJ Allergy Clin Immunol Pract20164345546326778246
   PubMed Web of Science ®Google Scholar
• Van SickleDBarrettMHumbletORandomized, controlled study of the impact of a mobile health tool on asthma SABA use, control and adherenceEur Respir J201648PA1018
   Google Scholar
• Van SickleDSuJBarrettMImpact of a mobile health pilot study on asthma rescue inhaler use, control and self-managementEur Respir J201546PA2528
   Web of Science ®Google Scholar
• Van SickleDMagzamenSTrueloveSOnline feedback about remotely monitored inhaled bronchodilators improves composite measures of asthma controlAm J Respir Crit Care Med2010181A3127
   Web of Science ®Google Scholar
• Van SickleDMorrisonTAWeekly feedback summarizing use of remotely monitored rescue medication improves asthma controlAm J Respir Crit Care Med2011183A4755
   Web of Science ®Google Scholar
• Van SickleDMagzamenSTrueloveSRemote monitoring of inhaled bronchodilator use and weekly feedback about asthma management: an open-group, short-term pilot study of the impact on asthma controlPLoS One201382e55335
   Web of Science ®Google Scholar
• Van SickleDBarrettMMarcusJHumbletOSmithTImpact of a technology-driven asthma program on symptoms, control and self-management: the clinical perspective142nd APHA Annual Meeting & Exposition 2014 Annual Meeting & ExpositionNew Orleans, LA, USA2014303269
   Google Scholar
• ChenJSJones-FordGSTuffliMBarrettMvan SickleDFeasibility and clinical impact of deploying a digital health intervention in a Medicare population with COPDAm J Respir Crit Care Med2017195A1722
   Web of Science ®Google Scholar
• BarrettMCombsVSuJGAIR Louisville: Addressing asthma with technology, crowdsourcing, cross-sector collaboration, and policyHealth Aff2018374525534
   PubMed Web of Science ®Google Scholar
• CarlJCIsakovDWinnersSUse of remote electronic monitoring improves asthma outcomes through improved adherenceAm J Resp Crit Care Med2018197A1164
   Web of Science ®Google Scholar
• HochHMeierMRBrintonJTSzeflerSJA feasibility study of daily monitoring of controller and rescue medication use in a pediatric patient population at high risk of an asthma exacerbationAm J Resp Crit Care Med2017195A198
   Web of Science ®Google Scholar
• KenyonCCGruschowSMQuarshieWOController adherence following hospital discharge in high risk children: a pilot randomized trial of text message remindersJ Asthma20181319
   Google Scholar
• SuJBarrettMHendersonKApplication of wireless inhaler sensors to enhance asthma surveillance and inform municipal interventionsAPHA 2016 Annual Meeting & ExpositionDenver, CO, USA20164382
   Google Scholar
• MerchantRTuffliMBarrettMImpact of a digital health intervention on asthma healthcare utilizationEur Respir J201750PA4692
   Web of Science ®Google Scholar
• European CommissionWhat does the general data protection regulation (GDPR) govern?2018 Available from. Available from: https://ec.europa.eu/info/law/law-topic/data-protection/reform/what-does-general-data-protection-regulation-gdpr-govern_enAccessed November 2018
   Google Scholar
• European UnionRegulation (EU) 2016/679 of the European Parliament and of the council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation)April 27, 2016 Available from https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32016R0679&from=ENAccessed November 2018
   Google Scholar
• BaroneDASingerBAMerkovLRamettaMSuarezGSurvey of US patients with multiple sclerosis: comparison of the new electronic interferon beta-1b autoinjector (BETACONNECT™) with mechanical autoinjectorsNeurol Ther20165215516727277705
   PubMed Web of Science ®Google Scholar
• BlakeyJDBenderBGDimaALDigital technologies and adherence in respiratory diseases: the road aheadEur Respir J2018525 180114722 11 2018
   PubMed Web of Science ®Google Scholar
• BlixenCSajatovicMMooreDJPatient participation in the development of a customized m-Health intervention to improve medication adherence in poorly adherent individuals with bipolar disorder (BD) and hypertension (HTN)Int J Healthc201841253530410985
   PubMedGoogle Scholar
• KalantarianHMotamedBAlshurafaNSarrafzadehMA wearable sensor system for medication adherence predictionArtif Intell Med201669435227068873
   PubMed Web of Science ®Google Scholar
• KlonoffDCKerrDSmart pens will improve insulin therapyJ Diabetes Sci Technol201812355155329411641
   PubMedGoogle Scholar
• JärvinenEMultanenJAtulaSSubcutaneous interferon β-1a administration by electronic auto-injector is associated with high adherence in patients with relapsing remitting multiple sclerosis in a real-life studyNeurol Int201791695728286627
   PubMed Web of Science ®Google Scholar
• VirdiNSKimYRajaPSavageGOsterbergLOptimizing treatment in patients with uncontrolled hypertension and type 2 diabetes by using a digital health offeringJ Am Soc Hypertens2016104e72e73
   Google Scholar
• JochmannANagakumarPHallPImprovement in asthma control and airway inflammation during a period of electronic monitoringEur Respir Soc201546OA4775
   Web of Science ®Google Scholar